Table 4.

Summary of costs of the current and alternative schemes in the public sector

Summary of adverse event cost	Total cost for AE category	Total cost per vaccine category	Programmatic total	Total
Current scheme (pentavalent vaccine + IPV)
Cost for 1st dose at 2 months	18,006,177	2,510,994	3,770,239	24,287,410
Cost for 2nd dose at 4 months	13,389,732	2,483,094	3,728,347	20,601,174
Cost for  3rd dose at 6 months	11,826,718	2,455,195	3,686,456	17,968,368
Cost for booster dose (15–18 months)#	11,199,664	2,426,542	3,738,931	17,365,137
Scheme total	55,422,291	9,875,826	14,923,972	80,222,090
Alternative scheme (hexavalent vaccine)
Cost for 1st dose at 2 months	6,174,079	12,555,578	1,890,471	20,620,127
Cost for 2nd dose at 4 months	5,499,117	12,416,071	1,869,465	19,784,653
Cost for 3rd dose at 6 months	6,065,325	12,276,565	1,848,460	20,190,350
Cost for booster dose (15–18 months)	7,437,880	12,416,071	1,869,465	21,723,417
Scheme total	25,176,401	49,664,285	7,477,861	82,318,548
Difference in total cost between schemes (alternative – current)	–30,245,890	39,788,459	–7,446,111	2,096,458

^#Booster dose, for the purposes of costs calculations, the IPV was included in the vaccination scheme of each child at the same time as the 4th pentavalent dose at age 15–18 months

All costs are in US$; AE, adverse event